{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T06:17:49Z","timestamp":1789107469183,"version":"build-2803163510"},"reference-count":99,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012246","name":"Priority Academic Program Development of Jiangsu Higher Education Institutions","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012246","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018556","name":"Science and Technology Program of Suzhou","doi-asserted-by":"publisher","award":["SYS2020093"],"award-info":[{"award-number":["SYS2020093"]}],"id":[{"id":"10.13039\/501100018556","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011349","name":"University of Texas at El Paso","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32170975"],"award-info":[{"award-number":["32170975"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32171437"],"award-info":[{"award-number":["32171437"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2019YFA0802400"],"award-info":[{"award-number":["2019YFA0802400"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011259","name":"State Key Laboratory of Robotics","doi-asserted-by":"publisher","award":["SKLP-O201905"],"award-info":[{"award-number":["SKLP-O201905"]}],"id":[{"id":"10.13039\/501100011259","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular Biology"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.jmb.2022.167457","type":"journal-article","created":{"date-parts":[[2022,1,16]],"date-time":"2022-01-16T09:20:20Z","timestamp":1642324820000},"page":"167457","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["The Ubiquitination-Dependent and -Independent Functions of Cereblon in Cancer and Neurological Diseases"],"prefix":"10.1016","volume":"434","author":[{"given":"Liang","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoqiang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmb.2022.167457_b0005","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1056\/NEJM199911183412110","article-title":"Thalidomide \u2014 A revival story","volume":"341","author":"Raje","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jmb.2022.167457_b0010","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1056\/NEJM199804163381607","article-title":"Drugs in pregnancy","volume":"338","author":"Koren","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jmb.2022.167457_b0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/toxsci\/kfr088","article-title":"Thalidomide: the tragedy of birth defects and the effective treatment of disease","volume":"122","author":"Kim","year":"2011","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.jmb.2022.167457_b0020","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3389\/fimmu.2017.00233","article-title":"A systematic review of immunological studies of erythema nodosum leprosum","volume":"8","author":"Polycarpou","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jmb.2022.167457_b0025","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/8371","article-title":"Thalidomide on the comeback trail","volume":"5","author":"Hales","year":"1999","journal-title":"Nature Med."},{"key":"10.1016\/j.jmb.2022.167457_b0030","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1056\/NEJMoa041668","article-title":"Efficacy of lenalidomide in myelodysplastic syndromes","volume":"352","author":"List","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jmb.2022.167457_b0035","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1056\/NEJMoa061292","article-title":"Lenalidomide in the myelodysplastic syndrome with chromosome 5q deletion","volume":"355","author":"List","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jmb.2022.167457_b0040","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1592\/phco.23.4.481.32115","article-title":"Thalidomide for erythema nodosum leprosum and other applications","volume":"23","author":"Okafor","year":"2003","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jmb.2022.167457_b0045","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1177\/2040620711413165","article-title":"The rise, fall and subsequent triumph of thalidomide: lessons learned in drug development","volume":"2","author":"Rehman","year":"2011","journal-title":"Ther. Adv. Hematol."},{"key":"10.1016\/j.jmb.2022.167457_b0050","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1126\/science.1177319","article-title":"Identification of a primary target of thalidomide teratogenicity","volume":"327","author":"Ito","year":"2010","journal-title":"Science (New York, NY)"},{"key":"10.1016\/j.jmb.2022.167457_b0055","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1126\/science.1244851","article-title":"Lenalidomide causes selective degradation of IKZF1 and IKZF3 in multiple myeloma cells","volume":"343","author":"Kr\u00f6nke","year":"2014","journal-title":"Science (New York, NY)"},{"key":"10.1016\/j.jmb.2022.167457_b0060","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1126\/science.1244917","article-title":"The myeloma drug lenalidomide promotes the cereblon-dependent destruction of Ikaros proteins","volume":"343","author":"Lu","year":"2014","journal-title":"Science (New York, NY)"},{"key":"10.1016\/j.jmb.2022.167457_b0065","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/nature14610","article-title":"Lenalidomide induces ubiquitination and degradation of CK1\u03b1 in del(5q) MDS","volume":"523","author":"Kr\u00f6nke","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.jmb.2022.167457_b0070","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/nm.4128","article-title":"Immunomodulatory drugs disrupt the cereblon\u2013CD147\u2013MCT1 axis to exert antitumor activity and teratogenicity","volume":"22","author":"Eichner","year":"2016","journal-title":"Nature Med."},{"key":"10.1016\/j.jmb.2022.167457_b0075","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.molcel.2020.12.046","article-title":"The IMiD target CRBN determines HSP90 activity toward transmembrane proteins essential in multiple myeloma","volume":"81","author":"Heider","year":"2021","journal-title":"Mol. Cell"},{"key":"10.1016\/j.jmb.2022.167457_b0080","doi-asserted-by":"crossref","first-page":"4771","DOI":"10.1182\/blood-2011-05-356063","article-title":"Cereblon expression is required for the antimyeloma activity of lenalidomide and pomalidomide","volume":"118","author":"Zhu","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jmb.2022.167457_b0085","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1212\/01.WNL.0000146196.01316.A2","article-title":"A mutation in a novel ATP-dependent Lon protease gene in a kindred with mild mental retardation","volume":"63","author":"Higgins","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.jmb.2022.167457_b0090","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1136\/jmedgenet-2016-104117","article-title":"A missense mutation in the CRBN gene that segregates with intellectual disability and self-mutilating behaviour in a consanguineous Saudi family","volume":"54","author":"Sheereen","year":"2017","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.jmb.2022.167457_b0095","first-page":"287","article-title":"What is the functional role of the thalidomide binding protein cereblon?","volume":"2","author":"Chang","year":"2011","journal-title":"Int. J. Biochem. Mol. Biol."},{"key":"10.1016\/j.jmb.2022.167457_b0100","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3109\/01677060903567849","article-title":"Temporal and spatial mouse brain expression of cereblon, an ionic channel regulator involved in human intelligence","volume":"24","author":"Higgins","year":"2010","journal-title":"J. Neurogenet."},{"key":"10.1016\/j.jmb.2022.167457_b0105","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.neures.2010.12.019","article-title":"mRNA distribution of the thalidomide binding protein cereblon in adult mouse brain","volume":"69","author":"Aizawa","year":"2011","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.jmb.2022.167457_b0110","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/0041-008X(65)90095-5","article-title":"Teratogenic effects of thalidomide in rabbits, rats, hamsters, and mice","volume":"7","author":"Fratta","year":"1965","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.jmb.2022.167457_b0115","doi-asserted-by":"crossref","first-page":"e38430","DOI":"10.7554\/eLife.38430","article-title":"Thalidomide promotes degradation of SALL4, a transcription factor implicated in Duane Radial Ray syndrome","volume":"7","author":"Donovan","year":"2018","journal-title":"eLife"},{"key":"10.1016\/j.jmb.2022.167457_b0120","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.bbrc.2016.06.091","article-title":"Nuclear cereblon modulates transcriptional activity of Ikaros and regulates its downstream target, enkephalin, in human neuroblastoma cells","volume":"477","author":"Wada","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jmb.2022.167457_b0125","doi-asserted-by":"crossref","first-page":"4012","DOI":"10.1038\/s41598-020-61027-w","article-title":"Genome-wide screening reveals a role for subcellular localization of CRBN in the anti-myeloma activity of pomalidomide","volume":"10","author":"Tateno","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jmb.2022.167457_b0130","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41419-019-1317-7","article-title":"Cereblon attenuates DNA damage-induced apoptosis by regulating the transcription-independent function of p53","volume":"10","author":"Zhou","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.jmb.2022.167457_b0135","doi-asserted-by":"crossref","first-page":"10141","DOI":"10.1074\/jbc.RA118.002246","article-title":"Cereblon suppresses the lipopolysaccharide-induced inflammatory response by promoting the ubiquitination and degradation of c-Jun","volume":"293","author":"Yang","year":"2018","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jmb.2022.167457_b0140","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.bbrc.2015.07.068","article-title":"Cereblon is recruited to aggresome and shows cytoprotective effect against ubiquitin-proteasome system dysfunction","volume":"464","author":"Sawamura","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jmb.2022.167457_b0145","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1093\/hmg\/ddx433","article-title":"Cereblon suppresses the formation of pathogenic protein aggregates in a p62-dependent manner","volume":"27","author":"Zhou","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.jmb.2022.167457_b0150","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1083\/jcb.143.7.1883","article-title":"Aggresomes: a cellular response to misfolded proteins","volume":"143","author":"Johnston","year":"1998","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.jmb.2022.167457_b0155","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nature18611","article-title":"A novel cereblon modulator recruits GSPT1 to the CRL4CRBN ubiquitin ligase","volume":"535","author":"Matyskiela","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.jmb.2022.167457_b0160","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/nature05175","article-title":"Molecular architecture and assembly of the DDB1-CUL4A ubiquitin ligase machinery","volume":"443","author":"Angers","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.jmb.2022.167457_b0165","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/nature13527","article-title":"Structure of the DDB1-CRBN E3 ubiquitin ligase in complex with thalidomide","volume":"512","author":"Fischer","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.jmb.2022.167457_b0170","doi-asserted-by":"crossref","first-page":"3924","DOI":"10.1038\/ncomms4924","article-title":"CRL4ACRBN E3 ubiquitin ligase restricts BK channel activity and prevents epileptogenesis","volume":"5","author":"Liu","year":"2014","journal-title":"Nature Commun."},{"key":"10.1016\/j.jmb.2022.167457_b0175","article-title":"Ubiquitin-dependent proteasomal degradation of AMPK gamma subunit by Cereblon inhibits AMPK activity","volume":"1867","author":"Yang","year":"2020","journal-title":"BBA"},{"key":"10.1016\/j.jmb.2022.167457_b0180","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.molcel.2016.02.032","article-title":"Glutamine triggers acetylation-dependent degradation of glutamine synthetase via the thalidomide receptor cereblon","volume":"61","author":"Nguyen","year":"2016","journal-title":"Mol. Cell"},{"key":"10.1016\/j.jmb.2022.167457_b0185","doi-asserted-by":"crossref","first-page":"3571","DOI":"10.1523\/JNEUROSCI.2081-17.2018","article-title":"Cereblon maintains synaptic and cognitive function by regulating BK channel","volume":"38","author":"Choi","year":"2018","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jmb.2022.167457_b0190","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1523\/JNEUROSCI.0599-17.2018","article-title":"Rescue of learning and memory deficits in the human nonsyndromic intellectual disability cereblon knock-out mouse model by targeting the AMP-activated protein kinase\u2013mTORC1 translational pathway","volume":"38","author":"Bavley","year":"2018","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jmb.2022.167457_b0195","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.bbr.2011.09.039","article-title":"Behavioral characterization of cereblon forebrain-specific conditional null mice: A model for human non-syndromic intellectual disability","volume":"226","author":"Rajadhyaksha","year":"2012","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.jmb.2022.167457_b0200","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/hon.2586","article-title":"Multiple myeloma: Every year a new standard?","volume":"37","author":"Rajkumar","year":"2019","journal-title":"Hematol. Oncol."},{"key":"10.1016\/j.jmb.2022.167457_b0205","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/nsmb.2874","article-title":"Structure of the human Cereblon\u2013DDB1\u2013lenalidomide complex reveals basis for responsiveness to thalidomide analogs","volume":"21","author":"Chamberlain","year":"2014","journal-title":"Nature Struct. Mol. Biol."},{"key":"10.1016\/j.jmb.2022.167457_b0210","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1038\/leu.2012.119","article-title":"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide","volume":"26","author":"Lopez-Girona","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.jmb.2022.167457_b0215","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.605989","article-title":"Caspase-8 inhibition prevents the cleavage and degradation of E3 ligase substrate receptor cereblon and potentiates its biological function","volume":"8","author":"Zhou","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.jmb.2022.167457_b0220","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1124\/jpet.121.000818","article-title":"Caspase-8 regulates the anti-myeloma activity of bortezomib and lenalidomide","volume":"379","author":"Zhou","year":"2021","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jmb.2022.167457_b0225","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1007\/s00109-012-0885-0","article-title":"Oncogenic CUL4A determines the response to thalidomide treatment in prostate cancer","volume":"90","author":"Ren","year":"2012","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.jmb.2022.167457_b0230","first-page":"215","article-title":"A cereblon modulator CC-885 induces CRBN- and p97-dependent PLK1 degradation and synergizes with volasertib to suppress lung cancer","volume":"18","author":"Li","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jmb.2022.167457_b0235","doi-asserted-by":"crossref","first-page":"263","DOI":"10.3390\/jpm11040263","article-title":"Multiomic analysis of cereblon expression and its prognostic value in kidney renal clear cell carcinoma, lung adenocarcinoma, and skin cutaneous melanoma","volume":"11","author":"Shin","year":"2021","journal-title":"J. Pers. Med."},{"key":"10.1016\/j.jmb.2022.167457_b0240","doi-asserted-by":"crossref","first-page":"3139","DOI":"10.1182\/blood.V122.21.3139.3139","article-title":"Absence Of mutation in cereblon (CRBN) and DNA damage binding protein 1 (DDB1) genes in myeloma cells and patients and its clinical significance","volume":"122","author":"Thakurta","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jmb.2022.167457_b0245","doi-asserted-by":"crossref","first-page":"e237","DOI":"10.3324\/haematol.2019.217943","article-title":"IKZF1\/3 and CRL4CRBN E3 ubiquitin ligase mutations and resistance to immunomodulatory drugs in multiple myeloma","volume":"105","author":"Santiago","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.jmb.2022.167457_b0250","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1038\/s41375-019-0403-2","article-title":"RUNX proteins desensitize multiple myeloma to lenalidomide via protecting IKZFs from degradation","volume":"33","author":"Zhou","year":"2019","journal-title":"Leukemia"},{"key":"10.1016\/j.jmb.2022.167457_b0255","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1182\/blood-2014-02-557819","article-title":"Identification of cereblon-binding proteins and relationship with response and survival after IMiDs in multiple myeloma","volume":"124","author":"Zhu","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jmb.2022.167457_b0260","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2018.10.003","article-title":"Pan-PIM kinase inhibitors enhance Lenalidomide's anti-myeloma activity via cereblon-IKZF1\/3 cascade","volume":"440\u2013441","author":"Zheng","year":"2019","journal-title":"Cancer Lett."},{"key":"10.1016\/j.jmb.2022.167457_b0265","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.3892\/ol.2017.6502","article-title":"Arsenic trioxide potentiates sensitivity of multiple myeloma cells to lenalidomide by upregulating cereblon expression levels","volume":"14","author":"Jian","year":"2017","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.jmb.2022.167457_b0270","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/s41375-018-0205-y","article-title":"A genome-scale CRISPR-Cas9 screening in myeloma cells identifies regulators of immunomodulatory drug sensitivity","volume":"33","author":"Liu","year":"2019","journal-title":"Leukemia"},{"key":"10.1016\/j.jmb.2022.167457_b0275","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1038\/sj.onc.1207414","article-title":"Nedd8 on cullin: building an expressway to protein destruction","volume":"23","author":"Pan","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.jmb.2022.167457_b0280","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.cell.2008.07.022","article-title":"Structural insights into NEDD8 activation of cullin-RING ligases: conformational control of conjugation","volume":"134","author":"Duda","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.jmb.2022.167457_b0285","doi-asserted-by":"crossref","first-page":"e1007165","DOI":"10.1371\/journal.pgen.1007165","article-title":"CRL4 antagonizes SCFFbxo7-mediated turnover of cereblon and BK channel to regulate learning and memory","volume":"14","author":"Song","year":"2018","journal-title":"PLoS Genet."},{"key":"10.1016\/j.jmb.2022.167457_b0290","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.bbrc.2018.11.058","article-title":"The interacting domains in cereblon differentially modulate the immunomodulatory drug-mediated ubiquitination and degradation of its binding partners","volume":"507","author":"Tao","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jmb.2022.167457_b0295","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1186\/s12885-016-2331-0","article-title":"Expression of the cereblon binding protein argonaute 2 plays an important role for multiple myeloma cell growth and survival","volume":"16","author":"Xu","year":"2016","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jmb.2022.167457_b0300","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.3390\/cells9061332","article-title":"CUL4-DDB1-CRBN E3 ubiquitin ligase regulates proteostasis of ClC-2 chloride channels: implication for aldosteronism and leukodystrophy","volume":"9","author":"Fu","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.jmb.2022.167457_b0305","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1111\/bjh.12708","article-title":"Immunomodulatory agents lenalidomide and pomalidomide co-stimulate T cells by inducing degradation of T cell repressors Ikaros and Aiolos via modulation of the E3 ubiquitin ligase complex CRL4CRBN","volume":"164","author":"Gandhi","year":"2014","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.jmb.2022.167457_b0310","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1182\/bloodadvances.2017010348","article-title":"IMiD compounds affect CD34+ cell fate and maturation via CRBN-induced IKZF1 degradation","volume":"2","author":"Li","year":"2018","journal-title":"Blood Adv."},{"key":"10.1016\/j.jmb.2022.167457_b0315","doi-asserted-by":"crossref","first-page":"4829","DOI":"10.1096\/fj.15-274050","article-title":"A novel effect of thalidomide and its analogs: suppression of cereblon ubiquitination enhances ubiquitin ligase function","volume":"29","author":"Liu","year":"2015","journal-title":"FASEB J."},{"key":"10.1016\/j.jmb.2022.167457_b0320","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1182\/blood.2019003257","article-title":"Cereblon harnesses Myc-dependent bioenergetics and activity of CD8+ T lymphocytes","volume":"136","author":"Hesterberg","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.jmb.2022.167457_b0325","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1038\/ni.2703","article-title":"Innate and adaptive immune cells in the tumor microenvironment","volume":"14","author":"Gajewski","year":"2013","journal-title":"Nature Immunol."},{"key":"10.1016\/j.jmb.2022.167457_b0330","first-page":"e315","article-title":"Proteasome inhibitors block Ikaros degradation by lenalidomide in multiple myeloma","volume":"100","author":"Shi","year":"2015","journal-title":"Haematologica"},{"key":"10.1016\/j.jmb.2022.167457_b0335","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/CAD.0000000000001041","article-title":"The paradoxical pharmacological mechanisms of lenalidomide and bortezomib in the treatment of multiple myeloma","volume":"32","author":"Wang","year":"2021","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.jmb.2022.167457_b0340","doi-asserted-by":"crossref","first-page":"29573","DOI":"10.1074\/jbc.M113.472092","article-title":"A mental retardation-linked nonsense mutation in cereblon is rescued by proteasome inhibition","volume":"288","author":"Xu","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jmb.2022.167457_b0345","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1111\/j.1471-4159.2005.03344.x","article-title":"Identification and functional characterization of cereblon as a binding protein for large-conductance calcium-activated potassium channel in rat brain","volume":"94","author":"Jo","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jmb.2022.167457_b0350","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/nature12481","article-title":"Self-propagation of pathogenic protein aggregates in neurodegenerative diseases","volume":"501","author":"Jucker","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.jmb.2022.167457_b0355","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1038\/nm1066","article-title":"Protein aggregation and neurodegenerative disease","volume":"10","author":"Ross","year":"2004","journal-title":"Nature Med."},{"key":"10.1016\/j.jmb.2022.167457_b0360","doi-asserted-by":"crossref","first-page":"17209","DOI":"10.1074\/jbc.M116.733626","article-title":"Amyloid precursor protein (APP) may act as a substrate and a recognition unit for CRL4CRBN and stub1 E3 ligases facilitating ubiquitination of proteins involved in presynaptic functions and neurodegeneration","volume":"291","author":"Del Prete","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jmb.2022.167457_b0365","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.bbrc.2020.01.078","article-title":"Cereblon-mediated degradation of the amyloid precursor protein via the ubiquitin-proteasome pathway","volume":"524","author":"Kurihara","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jmb.2022.167457_b0370","doi-asserted-by":"crossref","first-page":"11802","DOI":"10.1073\/pnas.1814446115","article-title":"Humanized cereblon mice revealed two distinct therapeutic pathways of immunomodulatory drugs","volume":"115","author":"Gemechu","year":"2018","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jmb.2022.167457_b0375","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1182\/blood-2018-05-852798","article-title":"CrbnI391V is sufficient to confer in vivo sensitivity to thalidomide and its derivatives in mice","volume":"132","author":"Fink","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.jmb.2022.167457_b0380","doi-asserted-by":"crossref","first-page":"8771","DOI":"10.1073\/pnas.1502166113","article-title":"Epigenetic regulation of Kcna3-encoding Kv1.3 potassium channel by cereblon contributes to regulation of CD4+ T-cell activation","volume":"113","author":"Kang","year":"2016","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jmb.2022.167457_b0385","doi-asserted-by":"crossref","first-page":"305","DOI":"10.5483\/BMBRep.2021.54.6.218","article-title":"Long-term depletion of cereblon induces mitochondrial dysfunction in cancer cells","volume":"54","author":"Park","year":"2021","journal-title":"BMB Rep."},{"key":"10.1016\/j.jmb.2022.167457_b0390","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.1021\/acschembio.8b00693","article-title":"Homo-PROTACs for the chemical knockdown of cereblon","volume":"13","author":"Steinebach","year":"2018","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.jmb.2022.167457_b0395","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/s41419-019-1562-9","article-title":"The homeobox transcription factor MEIS2 is a regulator of cancer cell survival and IMiDs activity in Multiple Myeloma: modulation by Bromodomain and Extra-Terminal (BET) protein inhibitors","volume":"10","author":"Abruzzese","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.jmb.2022.167457_b0400","doi-asserted-by":"crossref","first-page":"e2313","DOI":"10.1038\/cddis.2016.226","article-title":"Cereblon negatively regulates TLR4 signaling through the attenuation of ubiquitination of TRAF6","volume":"7","author":"Min","year":"2016","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.jmb.2022.167457_b0405","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.3389\/fimmu.2019.02203","article-title":"CRBN is a negative regulator of bactericidal activity and autophagy activation through inhibiting the ubiquitination of ECSIT and BECN1","volume":"10","author":"Kim","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jmb.2022.167457_b0410","doi-asserted-by":"crossref","first-page":"702","DOI":"10.3390\/ijms20030702","article-title":"TRAF6 silencing attenuates multiple myeloma cell adhesion to bone marrow stromal cells","volume":"20","author":"Morgan","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jmb.2022.167457_b0415","doi-asserted-by":"crossref","first-page":"10625","DOI":"10.1073\/pnas.1611751113","article-title":"Rabex-5 is a lenalidomide target molecule that negatively regulates TLR-induced type 1 IFN production","volume":"113","author":"Millrine","year":"2016","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jmb.2022.167457_b0420","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/imm.12922","article-title":"Inflammation in CNS neurodegenerative diseases","volume":"154","author":"Stephenson","year":"2018","journal-title":"Immunology"},{"key":"10.1016\/j.jmb.2022.167457_b0425","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1472-8206.2008.00616.x","article-title":"The lipopolysaccharide Parkinson's disease animal model: mechanistic studies and drug discovery","volume":"22","author":"Dutta","year":"2008","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.1016\/j.jmb.2022.167457_b0430","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1038\/s41589-019-0366-7","article-title":"p63 is a cereblon substrate involved in thalidomide teratogenicity","volume":"15","author":"Asatsuma-Okumura","year":"2019","journal-title":"Nature Chem. Biol."},{"key":"10.1016\/j.jmb.2022.167457_b0435","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1038\/s41589-018-0129-x","article-title":"SALL4 mediates teratogenicity as a thalidomide-dependent cereblon substrate","volume":"14","author":"Matyskiela","year":"2018","journal-title":"Nature Chem. Biol."},{"key":"10.1016\/j.jmb.2022.167457_b0440","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3390\/ph13050095","article-title":"Molecular mechanisms of the teratogenic effects of thalidomide","volume":"13","author":"Asatsuma-Okumura","year":"2020","journal-title":"Pharmaceuticals (Basel, Switzerland)"},{"key":"10.1016\/j.jmb.2022.167457_b0445","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.bbrc.2012.09.108","article-title":"Cereblon inhibits proteasome activity by binding to the 20S core proteasome subunit beta type 4","volume":"427","author":"Lee","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jmb.2022.167457_b0450","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.isci.2019.04.007","article-title":"Cereblon control of zebrafish brain size by regulation of neural stem cell proliferation","volume":"15","author":"Ando","year":"2019","journal-title":"iScience"},{"key":"10.1016\/j.jmb.2022.167457_b0455","doi-asserted-by":"crossref","first-page":"25120","DOI":"10.1074\/jbc.M116.757823","article-title":"Ohgata, the single drosophila ortholog of human cereblon, regulates insulin signaling-dependent organismic growth","volume":"291","author":"Wakabayashi","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jmb.2022.167457_b0460","doi-asserted-by":"crossref","first-page":"3748","DOI":"10.1021\/ja039025z","article-title":"Chemical genetic control of protein levels: selective in vivo targeted degradation","volume":"126","author":"Schneekloth","year":"2004","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jmb.2022.167457_b0465","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/s41392-019-0101-6","article-title":"PROTACs: great opportunities for academia and industry","volume":"4","author":"Sun","year":"2019","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jmb.2022.167457_b0470","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.chembiol.2017.09.010","article-title":"Lessons in PROTAC design from selective degradation with a promiscuous warhead","volume":"25","author":"Bondeson","year":"2018","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.jmb.2022.167457_b0475","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.apsb.2019.08.001","article-title":"Degradation of proteins by PROTACs and other strategies","volume":"10","author":"Wang","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"issue":"1","key":"10.1016\/j.jmb.2022.167457_b0480","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/17460441.2021.1969359","article-title":"Strategies for targeting undruggable targets","volume":"17","author":"Zhang","year":"2022","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.jmb.2022.167457_b0485","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.chembiol.2015.05.009","article-title":"Hijacking the E3 ubiquitin ligase cereblon to efficiently target BRD4","volume":"22","author":"Lu","year":"2015","journal-title":"Chem. Biol."},{"key":"10.1016\/j.jmb.2022.167457_b0490","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1126\/science.aab1433","article-title":"Phthalimide conjugation as a strategy for in vivo target protein degradation","volume":"348","author":"Winter","year":"2015","journal-title":"Science (New York, NY)"},{"key":"10.1016\/j.jmb.2022.167457_b0495","doi-asserted-by":"crossref","first-page":"5263","DOI":"10.1038\/s41467-021-25634-z","article-title":"The E3 ubiquitin ligase component, Cereblon, is an evolutionarily conserved regulator of Wnt signaling","volume":"12","author":"Shen","year":"2021","journal-title":"Nature Commun."}],"container-title":["Journal of Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022283622000213?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022283622000213?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T06:22:24Z","timestamp":1762669344000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022283622000213"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":99,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S0022283622000213"],"URL":"https:\/\/doi.org\/10.1016\/j.jmb.2022.167457","relation":{},"ISSN":["0022-2836"],"issn-type":[{"value":"0022-2836","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Ubiquitination-Dependent and -Independent Functions of Cereblon in Cancer and Neurological Diseases","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmb.2022.167457","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"167457"}}